Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

A phase II, multicenter, open-label study of obatoclax mesylate in patients with previously untreated myelodysplastic syndromes with anemia or thrombocytopenia.

A phase II, multicenter, open-label study of obatoclax mesylate in patients with previously... http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Clinical Lymphoma Myeloma & Leukemia Pubmed

A phase II, multicenter, open-label study of obatoclax mesylate in patients with previously untreated myelodysplastic syndromes with anemia or thrombocytopenia.

Clinical Lymphoma Myeloma & Leukemia , Volume 14 (6): -524 – Jul 23, 2015
Loading next page...
 
/lp/pubmed/a-phase-ii-multicenter-open-label-study-of-obatoclax-mesylate-in-6uRzYiVy5E

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Copyright
Copyright © 2014 Elsevier Inc. All rights reserved.
ISSN
2152-2650
eISSN
2152-2669
DOI
10.1016/j.clml.2014.04.007
pmid
25052051
Publisher site
See Article on Publisher Site

Abstract

Journal

Clinical Lymphoma Myeloma & LeukemiaPubmed

Published: Jul 23, 2015

There are no references for this article.